Authoritative References Raun K, Hansen BS, Johansen NL, Thgersen H, Madsen K, Ankersen M, Andersen PH
A meta-analysis evaluating indirectly GLP-1 receptor agonists and arrhythmias in patients with type 2 diabetes and myocardial infarction
However, starting any new medication, especially one designed for such profound physiological impact, requires a careful, informed approach
After helping clients through structured titration plans for 12 weeks , a clear pattern appeared: starting low, staying at each tolerated step for the recommended time, and keeping track of symptoms leads to fewer early dropouts and more steady fat loss
It does not predict how you will respond to Zepbound or any compound
You might wish to track cramping or other symptoms throughout the month to see if you notice a pattern